Vetter has announced a series of adjustments to its Development Service related structures designed to support its customer base. Effective October 1, Dr. Susanne Resatz, formerly manager, process development and manufacturing at the company’s clinical development facility in Chicago, Illinois, assumed the role of president, taking full responsibility for the site’s operations. Dr. Claudia Roth, formerly in this role, will repatriate to the company headquarters in Ravensburg, Germany, where she will head up the newly created “Innovation” department. Both Dr. Resatz and Dr. Roth have been with the US facility since its opening in 2009 and were instrumental in its early construction through to its becoming fully operational in October 2011. Vetter's Chicago facility is an expansion of Vetter Development Service, which employs more than 150 personnel in Europe and the United States.
Along with the management change at the Chicago facility, Vetter also announced that Dr. Paul Nelles, who headed Vetter´s global Development Service activities, will take early retirement after 11 years of service with Vetter. His replacement, Dr. Claus Feussner, formerly vice president of quality control, assumed the title of senior vice president of Vetter Development Service, effective September 1. Dr. Nelles will continue with his efforts at Vetter until mid-2015 to help with the transition.